2016
Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States
Sweet DE, Altice FL, Cohen CJ, Vandewalle B. Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States. PLOS ONE 2016, 11: e0147821. PMID: 26808503, PMCID: PMC4725959, DOI: 10.1371/journal.pone.0147821.Peer-Reviewed Original ResearchConceptsSingle-tablet regimensSubstantial price reductionsTenofovir disoproxil fumarate/emtricitabineCost-effectiveness thresholdIncremental cost-effectiveness ratioGeneric medicationsDaily single-tablet regimensDisoproxil fumarate/emtricitabineCost-effectiveness ratioElvitegravir/cobicistatCombination antiretroviral therapyHIV-1 patientsSingle-tablet regimenHigher inpatient costsHIV-1 infectionIncremental lifetime costPrice reductionEconomic outcomesMicrosimulation modelSuch policiesGeneric lamivudineTablet regimensAntiretroviral therapyU.S. settingsComplex regimens
2014
A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community
Di Paola A, Altice FL, Powell ML, Trestman RL, Springer SA. A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community. Health & Justice 2014, 2: 11. PMID: 25606368, PMCID: PMC4297667, DOI: 10.1186/s40352-014-0011-1.Peer-Reviewed Original ResearchMedical recordsHIV transmission risk behaviorsMini International Neuropsychiatric InterviewCohort of PLWHAPrevalence of PDCombination antiretroviral therapyAntiretroviral treatment adherenceTransmission risk behaviorsInternational Neuropsychiatric InterviewPsychiatric assessment toolsRetrospective data analysisObjective screening toolHIV/AIDSAntiretroviral therapyTreatment adherenceNeuropsychiatric InterviewHigh prevalencePsychiatric diagnosisPLWHARisk behaviorsPD assessmentPD diagnosisUniform screeningScreening toolHealthy outcomes
2012
Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients
Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, Shamai M, Amiri M, Nikaein S, Mansouri D, Masjedi M, Altice F. Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients. International Journal Of STD & AIDS 2012, 23: e1-e4. PMID: 23033530, PMCID: PMC3495268, DOI: 10.1258/ijsa.2009.009093.Peer-Reviewed Original ResearchConceptsCombination antiretroviral therapyTreatment outcomesTB/HIV co-infected patientsHIV co-infected patientsCat II treatmentCo-infected patientsTB-HIV patientsSerum albumin levelIntravenous drug useRisk of deathLower body weightHistory of imprisonmentAntiretroviral therapyLaboratory characteristicsTB treatmentTuberculosis patientsAlbumin levelsHIV transmissionMean ageII treatmentTB centersAlcohol abuseBetter outcomesPatientsBody weight
2011
Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components
Springer SA, Spaulding AC, Meyer JP, Altice FL. Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components. Clinical Infectious Diseases 2011, 53: 469-479. PMID: 21844030, PMCID: PMC3156144, DOI: 10.1093/cid/cir446.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCombination antiretroviral therapyPublic health implicationsTreatment outcomesPoor HIV treatment outcomesHuman immunodeficiency virus (HIV) infectionImmunodeficiency syndrome prevalenceHIV treatment outcomesImmunodeficiency virus infectionHealth implicationsMental illness treatmentSubstance use disordersCase management servicesAntiretroviral therapySecondary preventionSyndrome prevalenceTransitional careImmunological outcomesCriminal justice populationsVirus infectionIllness treatmentUse disordersHIVMental illnessAlcohol useMedical insurance
1998
Predictors of HIV Infection Among Newly Sentenced Male Prisoners
Altice F, Mostashari F, Selwyn P, Checko P, Singh R, Tanguay S, Blanchette E. Predictors of HIV Infection Among Newly Sentenced Male Prisoners. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 444-453. PMID: 9715840, DOI: 10.1097/00042560-199808150-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBlood TransfusionConfounding Factors, EpidemiologicConnecticutEmergency Medical ServicesForecastingHematologic DiseasesHepatitis, Viral, HumanHIV AntibodiesHIV SeropositivityHIV-1HumansMaleMental DisordersPrevalencePrimary Health CarePrisonersRisk FactorsSexual BehaviorSexually Transmitted DiseasesSubstance Abuse, IntravenousTuberculosisWounds, GunshotConceptsHIV infectionAppropriate risk-reduction interventionsPotent combination antiretroviral therapyElevated aspartate aminotransferase levelsSelf-reported high-risk behaviorsHIV testing resourcesCombination antiretroviral therapyHIV-seropositive personsInjection drug useAspartate aminotransferase levelsAge-adjusted ratesRisk reduction interventionsMultivariate regression analysisHigh-risk behaviorsPrevalence of individualsComprehensive HIVAntiretroviral therapyHIV careAminotransferase levelsHIV serosurveyIndependent predictorsLaboratory markersHIV statusHIV prevalenceBlack race